(Total Views: 104)
Posted On: 03/12/2018 10:35:15 AM
Post# of 4392
Ask down to 185M at .0002 now.
500M+ bid maintained at .0001 throughout 2018 with no significant fills in 13 weeks.
.0002 remains the price of entry for any significant amount ahead of 500% run to .0010+ at some point in 2018.
5 x CBD products earning revenue throughout 2017 Q4 - results soon.
7 x CBD products earning revenue in 2018 Q1.
Updates on Stackable Modular Grow Houses expected.
Updates on further acquisitions expected - using shares already in A/S.
Updates on additional CBD product launches expected.
500M+ bid maintained at .0001 throughout 2018 with no significant fills in 13 weeks.
.0002 remains the price of entry for any significant amount ahead of 500% run to .0010+ at some point in 2018.
5 x CBD products earning revenue throughout 2017 Q4 - results soon.
7 x CBD products earning revenue in 2018 Q1.
Updates on Stackable Modular Grow Houses expected.
Updates on further acquisitions expected - using shares already in A/S.
Updates on additional CBD product launches expected.
(0)
(0)
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
